Company Overview and News
Stop missing out on important events!
The court restrained RHC Holdings from operating its bank accounts except for payment of salaries and statutory dues till March 23, the next date of hearing.
Delhi High Court has attached all assets of RHC Holdings and Oscar Investments. The court has restrained RHC Holdings and Oscar Investments from working bank accounts. They can operate bank accounts for salary and statutory dues.
New Delhi: The Delhi high court on Monday issued a warrant of attachment against all the assets disclosed by Oscar Investments Ltd and RHC Holding Pvt. Ltd, owned by Ranbaxy promoters Malvinder and Shivinder Singh, in their 2 December 2016 and 14 March 2017 affidavits submitted to the court.
In a major blow to Singh brothers – the promoters of Fortis Healthcare and Religare Enterprises – the Delhi high court in its interim order on Monday attached all assets of RHC Holdings and Oscar Investments.
New Delhi: The Supreme Court on Thursday refused to pass any interim order to permit banks to sell shares pledged by Malvinder Singh and Shivinder Singh in Fortis Healthcare Holding Pvt. Ltd. (17-0)
New Delhi: Religare Enterprises Ltd, promoted by brothers Shivinder Singh and Malvinder Singh, told on Wednesday the Delhi high court that the sale of its health insurance business is unlikely to happen this year. (4-0)
New Delhi: The Supreme Court on Friday directed former Ranbaxy promoters, Malvinder and Shivender Singh, to maintain status quo with regard to their stake in Fortis Healthcare Ltd.
India Ratings has downgraded NCDs of RHC Holding at a time when Singh brothers are in talks with banks to meet repayment obligations of Religare Enterprises
Fortis Healthcare Holdings has been selling its unencumbered assets without applying to the court, says Daiichi Sankyo
The Delhi High Court on Tuesday asked RHC Holdings and Oscar Investments (companies owned by former Ranbaxy promoters Malvinder and Shivinder Singh) to respond by August 10 to a contempt application filed against them by Japanese pharmaceutical major Daiichi Sankyo.
The order to allow conditional stake sale by Singh brothers in Fortis Healthcare was passed to afford protection to Daiichi Sankyo in terms of ready realizable value of assets at a later stage
IHH Healthcare to buy 26% stake in Fortis from Malvinder and Shivinder Singh; both sides agree to a combined $2.9 billion valuation for Fortis and SRL Diagnostics
Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.
Daiichi Sankyo approached the Delhi High Court on Monday to protest against the 80 percent stake sale of Religare Health Insurance by former Ranbaxy promoter's Malvinder and Shivinder Singh. The objection to the April 9 sale of Religare's insurance business with private equity fund True North Managers marks Daiichi's latest attempt at securing the assets of the Singh brothers for the realisation of a Rs 2,562 crore Singapore arbitration award in favour of the Japanese pharmaceutical major.
The latest turn in a long running legal brawl with Daiichi Sankyo means Shivinder Singh and Malvinder Singh can’t change the status of their holdings without first getting permission from the Delhi high court